Biotechnology Stocks Are Ripe For A Sharp Bounce
After a historically strong rally in recent years, Biotechnology stocks and the Nasdaq Biotechnology Index ETF (IBB) finally exhausted themselves in 2015 and began to tumble. So far in 2016 biotechnology has been on a one-way street lower but for the near-term increasingly look to be oversold. Active investors and Traders could look to play […]
Why the threat of recession makes it a great year for trading
You might think that seasoned equity trader Serge Berger is sitting at his desk with his head in his hands, after all it’s been a bleak start to the year. The S&P 500 has been smashed; with energy stocks seeing EPS down around 70% year on year. This earnings season has revealed even more wounding […]